Dianthus Therapeutics, Inc

The annual 10-K, the quarterly 10-Q and the 8-K filed between them when something material happens.

1. Aug 1313GPassive stake of 5% or more (13G), filed by Wellington Management Group Llp
2. Aug 713GPassive stake of 5% or more (13G), filed by T. Rowe Price Investment Management
3. Aug 410-QQuarterly report
4. Aug 48-KResults of operations2.029.01
5. Jun 128-KOther events8.019.01
6. May 228-KShareholder vote5.07
7. May 510-QQuarterly report
8. May 58-KResults of operations2.029.01
9. Mar 268-KOther events8.019.01
10. Mar 128-KMaterial agreement1.019.01
11. Mar 11424B5Prospectus for an offering
12. Mar 9424B5Prospectus for an offering
13. Mar 910-KAnnual report
14. Mar 98-KResults of operations and Regulation FD disclosure2.027.018.01
15. Jan 28S-3Shelf registration
16. Jan 128-KResults of operations and Regulation FD disclosure2.027.019.01
17. Nov 5, 202510-QQuarterly report
18. Nov 5, 20258-KResults of operations2.029.01
19. Nov 3, 20258-KOther events8.019.01
20. Oct 16, 20258-KMaterial agreement and results of operations1.012.028.019.01
21. Sep 11, 20258-KMaterial agreement1.019.01
22. Sep 10, 2025424B5Prospectus for an offering
23. Sep 8, 2025424B5Prospectus for an offering
24. Sep 8, 20258-KRegulation FD disclosure and other events7.018.019.01
25. Aug 7, 202510-QQuarterly report
26. Aug 7, 20258-KResults of operations2.029.01
27. May 22, 20258-KOfficer or director change and shareholder vote5.025.07
28. May 12, 202510-QQuarterly report
29. May 12, 20258-KResults of operations2.029.01
30. Mar 11, 202510-KAnnual report
31. Mar 11, 20258-KResults of operations2.029.01
32. Mar 5, 20258-KOfficer or director change5.02
33. Dec 12, 20248-KOther events8.019.01
34. Nov 7, 202410-QQuarterly report
35. Nov 7, 20248-KResults of operations2.029.01
36. Oct 11, 2024424B5Prospectus for an offering
37. Oct 11, 2024424B3Prospectus for an offering